title: Randomized controlled trial of interventions for young people at ultra high risk for psychosis: 6-month analysis.
authors.affiliation: Orygen Research Centre and University of Melbourne, Department of Psychiatry, 35 Poplar Rd, Parkville 3052, Victoria, Australia. aryung@unimelb.edu.au
authors.forename: Alison R
authors.initials: AR
authors.lastname: Yung
authors.forename: Lisa J
authors.initials: LJ
authors.lastname: Phillips
authors.forename: Barnaby
authors.initials: B
authors.lastname: Nelson
authors.forename: Shona M
authors.initials: SM
authors.lastname: Francey
authors.forename: Hok
authors.initials: H
authors.lastname: PanYuen
authors.forename: Magenta B
authors.initials: MB
authors.lastname: Simmons
authors.forename: Margaret L
authors.initials: ML
authors.lastname: Ross
authors.forename: Daniel
authors.initials: D
authors.lastname: Kelly
authors.forename: Kathryn
authors.initials: K
authors.lastname: Baker
authors.forename: G Paul
authors.initials: GP
authors.lastname: Amminger
authors.forename: Gregor
authors.initials: G
authors.lastname: Berger
authors.forename: Andrew D
authors.initials: AD
authors.lastname: Thompson
authors.forename: Annette
authors.initials: A
authors.lastname: Thampi
authors.forename: Patrick D
authors.initials: PD
authors.lastname: McGorry
mesh_terms: D000293:Adolescent; D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D015928:Cognitive Behavioral Therapy; D003131:Combined Modality Therapy; D003376:Counseling; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D055118:Medication Adherence; D011569:Psychiatric Status Rating Scales; D011788:Quality of Life / Q000523:psychology; D012307:Risk Factors; D018967:Risperidone / Q000009:adverse effects / Q000627:therapeutic use*; D012559:Schizophrenia / Q000188:drug therapy / Q000628:therapy*; D012917:Social Adjustment; D012944:Social Support; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D014150:Antipsychotic Agents; D018967:Risperidone